Learn Best Practices for Managing Adverse Events Associated With Novel Therapies for Patients With Hematologic Malignancies

Jae H. Park MD and Anas Younes MD provide expert perspectives on identifying and managing CRS and TLS for your patients being treated for various hematologic malignancies. These activities include commentaries with expert insights on CRS and TLS along with shareable downloadable slidesets.

Share

Program Content

No activities added yet

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Sanofiaventis Cardio